ICCC – immucell corporation (US:NASDAQ)

News

ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]
ImmuCell (NASDAQ:ICCC) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition [Seeking Alpha]
ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript [Seeking Alpha]
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com